Germfree has released bioGO, a biomanufacturing platform that represents a new approach to quick and flexible production space. The company created bioGO in response to limited and rigid infrastructure options for launching biopharmaceutical projects. According to the company, the Adaptive Platform delivers advanced mobile and modular bioprocess suites that provide greater flexibility and scalability to keep up with the rapid pace of innovation.

The company noted, while the number of new biotech startups and emerging therapeutics are growing rapidly, many biopharmaceutical projects lack viable R&D and production space. Bioprocess engineering and technologies have continued to advance but infrastructure options that bring speed and flexibility have lagged. This has created the demand for facilities that are optimized for the current stage of development and can be readily scaled up as production needs increase.

“The bioGO Platform represents the future of GMP compliant cleanrooms and biocontainment spaces,” according to Kevin Kyle, president of Germfree. “Our facilities are fully adaptable to customer requirements and process changes. bioGO Mobile can literally be rolled up for a campaign, or any short-term need, while bioGO Modular offers permanent installations that can still be repurposed and relocated. Our proprietary technology for connecting multiple bioGO units allows for maximum flexibility of size and layout. These factory-built modules provide a fast-track to a validated bioprocessing suite, normally in half the time of traditional construction.”